Effectiveness and Adherence to an Online Sleep Program

NCT01440777 | Completed

• 1 other identifier: IRB# 11-860
• Study Type: interventional
• Target: 101
• Locations: 1 country
• Sites: 1

Brief Summary

This research will examine the effectiveness of a 6-week online sleep program (Go! To Sleep) which provides a set of various psycho-educational materials and behavioral techniques to reduce insomnia symptoms, improve sleep, and improve quality of life.

Conditions

Insomnia

Keywords

Insomnia; Sleep; Stress; Online program; Web-based program; Cognitive Behavioral Therapy for Insomnia (CBT-i)

Outcome Measures

Primary Outcomes (1)

• Insomnia severity

  To assess the effectiveness of the online Go! to Sleep program in improving sleep by measuring insomnia severity using the Insomnia Severity Index (ISI).

  5 months

Secondary Outcomes (5)

• Insomnia symptoms

  5 months

• Sleep pattern

  5 months

• Daytime Dysfunction

  5 months

• Stress

  5 months

• Program adherence

  5 months

Study Arms (2)

Go! to Sleep

ACTIVE COMPARATOR

Participants access and utilize the 6-week online program that provides a set of various psycho-educational materials and behavioral techniques to treat insomnia.

Behavioral: Go! to Sleep

Control Group

NO INTERVENTION

No intervention provided. These participants will receive the Go! to Sleep program after the research trial has been completed (10 weeks after registration).

Interventions

Go! to Sleep BEHAVIORAL

The online program provides various tools for the delivery of the intervention including: * Daily articles * Daily activities to help get the sleep you need * Daily sleep improvement recommendations * Audio recorded relaxation exercises * Daily e-mails from your program coach * Personal progress charts * An online sleep log and daily sleep score

Go! to Sleep

Eligibility Criteria

• Age: 18 Years - 89 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Age 18 to 70 years old.
• Currently living in the continental United States and Canada.
• Symptoms of insomnia based on the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) definition of insomnia disorder:
• Self-reported sleep difficulties (including sleep-onset latency, waking after sleep onset, early waking of more than 30 min duration) 3 or more times a week in the past 3 months.
• Self-reported insomnia problem for more than 3 months.
• Self-reported significant daytime impairment due to sleep difficulties.
• Willingness to log onto the internet on a regular basis for the duration of the study (3-7 months).
• Willingness and able to complete almost daily a sleep log to track sleep pattern for up to 2 months at a time (approximately 2-3 min daily).
• Willingness to be in the Wait-list control group and not have access to the program for 3 months.

You may not qualify if:

• Pregnant or planning to be pregnant in the next 6 months.
• Lack of internet access and/or Mac computer at place of residence.
• Currently participating or have participated in group or individual therapy for insomnia in the prior month.
• Patient Health Questionnaire (PHQ9) depression score \>14.
• Recent treatment (less than 3 months) or medication for depression or anxiety.
• Change in treatment or medication for depression or anxiety in the past month or planned change in the next 3 months.
• Current treatment (therapy, prescription) for any other psychological or emotional conditions (including but not limited to: mania, manic-depression, psychosis, schizophrenia, adjustment disorder).
• Diagnosed and currently suffering from a sleep disorder (including, but not limited to sleep apnea, restless leg syndrome, sleep walking, narcolepsy) which is untreated or has been treated for less than a month.
• Suffer from physical symptoms or medical conditions that may affect sleep (including but not limited to: pain, arthritis, tinnitus, diabetes, night time cough, shortness of breath, hot flashes, frequent urination, heartburn).
• Steroid an stimulant use (including but not limited to prednisone, methylprednisolone or Solumedrol (for inflammatory disorders), methylphenidate, or Ritalin (for Attention-Deficit Hyperactivity disorder), Provigil (for narcolepsy), Wellbutrin or Zyban (for tobacco cessation), cocaine or methylenedioxymethamphetamine (MDMA) (a.k.a. Ecstasy)).
• Irregular workshift.
• Having young children who may affect sleep pattern.
• Taking over-the-counter or prescribed sleep medication 3 or more times a week.
• Alcoholism.
• Inability to access the internet on a consistent regular basis for the duration of the study (3-7 months).

Sponsors & Collaborators

• The Cleveland Clinic: lead

Study Sites (1)

Cleveland Clinic Foundation

Cleveland, Ohio, 44195, United States

Location

MeSH Terms

Conditions

Sleep Initiation and Maintenance Disorders

Condition Hierarchy (Ancestors)

Sleep Disorders, Intrinsic; Dyssomnias; Sleep Wake Disorders; Nervous System Diseases; Mental Disorders

Study Officials

• Adam Bernstein, M.D.

  The Cleveland Clinic

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: OTHER
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Research Coordinator

Study Record Dates

• First Submitted: September 23, 2011
• First Posted: September 27, 2011
• Study Start: October 1, 2011
• Primary Completion: April 1, 2014
• Study Completion: June 1, 2014
• Last Updated: May 11, 2022

Record last verified: 2022-05

Locations

US (1)